ロード中...
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine
We investigated CD25 expression in older (≥60 years) patients with new acute myelogenous leukemia treated with decitabine and plerixafor. Patients resistant to therapy or survival ≤1 year had significantly higher percentages of CD25(pos) myeloid blasts in baseline bone marrow. CD25(pos) patients had...
保存先:
| 出版年: | Leuk Lymphoma |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5773411/ https://ncbi.nlm.nih.gov/pubmed/28718760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1352089 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|